These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
772 related articles for article (PubMed ID: 28327158)
1. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature. Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158 [TBL] [Abstract][Full Text] [Related]
2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer. He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature. Liang JW; Zhang JJ; Zhang T; Zheng ZC Tumour Biol; 2014 May; 35(5):4849-58. PubMed ID: 24449506 [TBL] [Abstract][Full Text] [Related]
4. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis. Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis. Wang HB; Liao XF; Zhang J Medicine (Baltimore); 2017 Nov; 96(44):e8437. PubMed ID: 29095284 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance. Yu GZ; Chen Y; Wang JJ J Cancer Res Clin Oncol; 2009 Oct; 135(10):1331-9. PubMed ID: 19337752 [TBL] [Abstract][Full Text] [Related]
7. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China. Shen GS; Zhao JD; Zhao JH; Ma XF; Du F; Kan J; Ji FX; Ma F; Zheng FC; Wang ZY; Xu BH World J Gastroenterol; 2016 Jun; 22(23):5406-14. PubMed ID: 27340357 [TBL] [Abstract][Full Text] [Related]
8. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test. Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863 [TBL] [Abstract][Full Text] [Related]
9. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer. Bădescu A; Georgescu CV; Vere CC; Crăiţoiu S; Grigore D Rom J Morphol Embryol; 2012; 53(4):997-1005. PubMed ID: 23303024 [TBL] [Abstract][Full Text] [Related]
10. The Role of Human Epidermal Growth Factor Receptor (HER2/neu) in the Prognosis of Patients with Gastric Cancer. Aznab M; Maleksabet D; Khazaei S; Khazaei M; Rezaei M Asian Pac J Cancer Prev; 2019 Jul; 20(7):1989-1994. PubMed ID: 31350955 [TBL] [Abstract][Full Text] [Related]
11. Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients. Cao GD; Chen K; Chen B; Xiong MM BMC Cancer; 2017 Dec; 17(1):841. PubMed ID: 29233126 [TBL] [Abstract][Full Text] [Related]
12. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis. Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray. Rakhshani N; Kalantari E; Bakhti H; Sohrabi MR; Mehrazma M Asian Pac J Cancer Prev; 2014; 15(18):7597-602. PubMed ID: 25292034 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma. Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays. Kim KC; Koh YW; Chang HM; Kim TH; Yook JH; Kim BS; Jang SJ; Park YS Ann Surg Oncol; 2011 Oct; 18(10):2833-40. PubMed ID: 21468783 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Variation of Lauren Classification in Gastric Cancer. Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923 [TBL] [Abstract][Full Text] [Related]
17. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis. Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108 [TBL] [Abstract][Full Text] [Related]
18. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189 [TBL] [Abstract][Full Text] [Related]
19. Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stages. Abdel-Aziz A; Ahmed RA; Ibrahiem AT Ann Diagn Pathol; 2017 Oct; 30():1-7. PubMed ID: 28965621 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of HER2 Expression for Gastric Cancer With Clinically Para-aortic Lymph Node Metastasis. Arigami T; Matsushita D; Okubo K; Sasaki K; Tsuruda Y; Kita Y; Mori S; Yanagita S; Uenosono Y; Kurahara H; Ohtsuka T Anticancer Res; 2021 Jun; 41(6):3099-3107. PubMed ID: 34083303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]